[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Dapagliflozin 10 mg: Patients will be randomized 1:1 to either dapagliflozin 10 mg or placebo once daily per oral use. Every attempt should be made to maintain patients on dapagliflozin 10 mg or matching placebo during the course of the study. The investigational product should be taken as soon as possible after randomization and then once daily in the morning; at approximately the same time every day; during the 30-day treatment periodControl Intervention1: Matching placebo: Patients will be randomized 1:1 to either dapagliflozin 10 mg or placebo once daily per oral use. Every attempt should be made to maintain patients on dapagliflozin 10 mg or matching placebo during the course of the study.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Dapagliflozin 10 mg: Patients will be randomized 1:1 to either dapagliflozin 10 mg or placebo once daily per oral use. Every attempt should be made to maintain patients on dapagliflozin 10 mg or matching placebo during the course of the study. The investigational product should be taken as soon as possible after randomization and then once daily in the morning; at approximately the same time every day; during the 30-day treatment period", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Matching placebo: Patients will be randomized 1:1 to either dapagliflozin 10 mg or placebo once daily per oral use. Every attempt should be made to maintain patients on dapagliflozin 10 mg or matching placebo during the course of the study.", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 379, "treatment_name": "Dapagliflozin", "treatment_type": "Metabolic agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Dapagliflozin 10 mg: Patients will be randomized 1:1 to either dapagliflozin 10 mg or placebo once daily per oral use. Every attempt should be made to maintain patients on dapagliflozin 10 mg or matching placebo during the course of the study. The investigational product should be taken as soon as possible after randomization and then once daily in the morning; at approximately the same time every day; during the 30-day treatment periodControl Intervention1: Matching placebo: Patients will be randomized 1:1 to either dapagliflozin 10 mg or placebo once daily per oral use. Every attempt should be made to maintain patients on dapagliflozin 10 mg or matching placebo during the course of the study.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Dapagliflozin 10 mg: Patients will be randomized 1:1 to either dapagliflozin 10 mg or placebo once daily per oral use. Every attempt should be made to maintain patients on dapagliflozin 10 mg or matching placebo during the course of the study. The investigational product should be taken as soon as possible after randomization and then once daily in the morning; at approximately the same time every day; during the 30-day treatment period", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Matching placebo: Patients will be randomized 1:1 to either dapagliflozin 10 mg or placebo once daily per oral use. Every attempt should be made to maintain patients on dapagliflozin 10 mg or matching placebo during the course of the study.", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Dapagliflozin 10 mg: Patients will be randomized 1:1 to either dapagliflozin 10 mg or placebo once daily per oral use. Every attempt should be made to maintain patients on dapagliflozin 10 mg or matching placebo during the course of the study. The investigational product should be taken as soon as possible after randomization and then once daily in the morning; at approximately the same time every day; during the 30-day treatment periodControl Intervention1: Matching placebo: Patients will be randomized 1:1 to either dapagliflozin 10 mg or placebo once daily per oral use. Every attempt should be made to maintain patients on dapagliflozin 10 mg or matching placebo during the course of the study.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Dapagliflozin 10 mg: Patients will be randomized 1:1 to either dapagliflozin 10 mg or placebo once daily per oral use. Every attempt should be made to maintain patients on dapagliflozin 10 mg or matching placebo during the course of the study. The investigational product should be taken as soon as possible after randomization and then once daily in the morning; at approximately the same time every day; during the 30-day treatment period", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Matching placebo: Patients will be randomized 1:1 to either dapagliflozin 10 mg or placebo once daily per oral use. Every attempt should be made to maintain patients on dapagliflozin 10 mg or matching placebo during the course of the study.", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]